BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15766946)

  • 21. Dose dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama).
    Skálová L; Szotáková B; Machala M; Neca J; Soucek P; Havlasová J; Wsól V; Krídová L; Kvasnicková E; Lamka J
    Chem Biol Interact; 2001 Aug; 137(2):155-67. PubMed ID: 11551531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small intestinal sulphoxidation of albendazole.
    Villaverde C; Alvarez AI; Redondo P; Voces J; Del Estal JL; Prieto JG
    Xenobiotica; 1995 May; 25(5):433-41. PubMed ID: 7571717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition kinetics of albendazole and metabolites in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of amphiphilic surfactant agents on the gastrointestinal absorption of albendazole in cattle.
    Virkel G; Imperiale F; Lifschitz A; Pis A; Alvarez A; Merino G; Prieto J; Lanusse C
    Biopharm Drug Dispos; 2003 Apr; 24(3):95-103. PubMed ID: 12673667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo.
    Bártíková H; Vokřál I; Skálová L; Lamka J; Szotáková B
    Xenobiotica; 2010 Sep; 40(9):593-601. PubMed ID: 20560773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transport of albendazole and albendazole sulphoxide in the lancet fluke (Dicrocoelium dendriticum).
    Bártíková H; Vokřál I; Forstová-Křížová V; Skálová L; Lamka J; Szotáková B
    Vet Parasitol; 2011 Feb; 176(1):27-33. PubMed ID: 21075525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.
    Aksit D; Yalinkilinc HS; Sekkin S; Boyacioğlu M; Cirak VY; Ayaz E; Gokbulut C
    BMC Vet Res; 2015 May; 11():124. PubMed ID: 26012791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.
    Dib A; Palma S; Suárez G; Farías C; Cabrera P; Castro S; Allemandi D; Moreno L; Lanusse C; Sánchez Bruni S
    J Vet Pharmacol Ther; 2011 Apr; 34(2):136-41. PubMed ID: 21395604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in plasma and abomasal kinetics of albendazole and its metabolites in calves grazed on pasture or fed a grain-based diet.
    Sánchez S; Alvarez L; Pis A; Quiroga M; Lanusse C
    Res Vet Sci; 1999 Jun; 66(3):223-30. PubMed ID: 10333463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques.
    Kalaiselvan R; Mohanta GP; Madhusudan S; Manna PK; Manavalan R
    Pharmazie; 2007 Aug; 62(8):604-7. PubMed ID: 17867556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves.
    Sánchez SF; Alvarez LI; Lanusse CE
    J Vet Pharmacol Ther; 1997 Feb; 20(1):38-47. PubMed ID: 9049948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    J Vet Pharmacol Ther; 1999 Apr; 22(2):77-86. PubMed ID: 10372592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
    Benoit E; Besse S; Delatour P
    Am J Vet Res; 1992 Sep; 53(9):1663-5. PubMed ID: 1416373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residue depletion of albendazole and its metabolites in the muscle tissue of large mouth and hybrid striped bass after oral administration.
    Shaikh B; Rummel N; Gieseker C; Cheely CS; Reimschuessel R
    J Chromatogr A; 2009 Nov; 1216(46):8173-6. PubMed ID: 19406409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of bioactive phytochemicals and synthetic anthelmintics: In vivo and in vitro assessment of the albendazole-thymol association.
    Miró MV; E Silva CR; Viviani P; Luque S; Lloberas M; Costa-Júnior LM; Lanusse C; Virkel G; Lifschitz A
    Vet Parasitol; 2020 May; 281():109121. PubMed ID: 32361524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.